Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
6
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
6
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
6
×
texas blog main
texas top stories
wisconsin blog main
6
×
wisconsin top stories
boston top stories
clinical trials
eli lilly
alzheimer's disease
astrazeneca
cancer immunotherapy
deals
fda
merck
biogen
bristol-myers squibb
What
bio
6
×
roundup
drug
companies
week
acquisitions
ceo
daniel
debut
gilead
moves
nash
news
o’day
sciences
alzheimer’s
announced
annual
approval
approved
assessed
attention
biggest
biogen’s
biopharmaceutical
biotech
black
build
buy
collabs
communities
company’s
conference
continue
convo
covid
deal
diamond
diamond’s
digital
Language
unset
Current search:
cancer
×
bio
×
" wisconsin blog main "
×
abbvie
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More